Cargando…

Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients

The goal of this study was to investigate microRNAs (miRs) expression at different stages of nasopharyngeal carcinoma (NPC). MiR expression profiling at various stages of NPC was performed by miR array and further verified using quantitative real‐time RT‐PCR. Pathway enrichment analysis was carried...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shuna, Hang, Lihua, Ma, Yongming, Wu, Chaoyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134390/
https://www.ncbi.nlm.nih.gov/pubmed/27489139
http://dx.doi.org/10.1111/jcmm.12906
_version_ 1782471447520739328
author Li, Shuna
Hang, Lihua
Ma, Yongming
Wu, Chaoyang
author_facet Li, Shuna
Hang, Lihua
Ma, Yongming
Wu, Chaoyang
author_sort Li, Shuna
collection PubMed
description The goal of this study was to investigate microRNAs (miRs) expression at different stages of nasopharyngeal carcinoma (NPC). MiR expression profiling at various stages of NPC was performed by miR array and further verified using quantitative real‐time RT‐PCR. Pathway enrichment analysis was carried out to identify the functional pathways regulated by the miRs. The expression of a selected group of identified miRs was verified in stage I NPC by in situ hybridization (ISH). A total of 449 miRs were identified with significantly different expressions between NPC tissues and normal pharyngeal tissues. Eighty‐four miRs were dysregulated only in stage I NPC, among which 45 miRs were up‐regulated and the other 39 were down‐regulated. Pathway enrichment assay revleaed that three significantly down‐regulated and three significantly up‐regulated miRs involved in 12 pathways associating with tumour formation and progression. Quantitative RT‐PCR confirmed the miR array result. In addition, the low expression levels of hsa‐miR‐4324, hsa‐miR‐203a and hsa‐miR‐199b‐5p were further validated in stage I NPC by ISH. This present study identifed the miR signature in stage I NPC, providing the basis for early detection and treatment of NPC.
format Online
Article
Text
id pubmed-5134390
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-51343902016-12-15 Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients Li, Shuna Hang, Lihua Ma, Yongming Wu, Chaoyang J Cell Mol Med Original Articles The goal of this study was to investigate microRNAs (miRs) expression at different stages of nasopharyngeal carcinoma (NPC). MiR expression profiling at various stages of NPC was performed by miR array and further verified using quantitative real‐time RT‐PCR. Pathway enrichment analysis was carried out to identify the functional pathways regulated by the miRs. The expression of a selected group of identified miRs was verified in stage I NPC by in situ hybridization (ISH). A total of 449 miRs were identified with significantly different expressions between NPC tissues and normal pharyngeal tissues. Eighty‐four miRs were dysregulated only in stage I NPC, among which 45 miRs were up‐regulated and the other 39 were down‐regulated. Pathway enrichment assay revleaed that three significantly down‐regulated and three significantly up‐regulated miRs involved in 12 pathways associating with tumour formation and progression. Quantitative RT‐PCR confirmed the miR array result. In addition, the low expression levels of hsa‐miR‐4324, hsa‐miR‐203a and hsa‐miR‐199b‐5p were further validated in stage I NPC by ISH. This present study identifed the miR signature in stage I NPC, providing the basis for early detection and treatment of NPC. John Wiley and Sons Inc. 2016-08-04 2016-12 /pmc/articles/PMC5134390/ /pubmed/27489139 http://dx.doi.org/10.1111/jcmm.12906 Text en © 2016 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Li, Shuna
Hang, Lihua
Ma, Yongming
Wu, Chaoyang
Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients
title Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients
title_full Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients
title_fullStr Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients
title_full_unstemmed Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients
title_short Distinctive microRNA expression in early stage nasopharyngeal carcinoma patients
title_sort distinctive microrna expression in early stage nasopharyngeal carcinoma patients
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134390/
https://www.ncbi.nlm.nih.gov/pubmed/27489139
http://dx.doi.org/10.1111/jcmm.12906
work_keys_str_mv AT lishuna distinctivemicrornaexpressioninearlystagenasopharyngealcarcinomapatients
AT hanglihua distinctivemicrornaexpressioninearlystagenasopharyngealcarcinomapatients
AT mayongming distinctivemicrornaexpressioninearlystagenasopharyngealcarcinomapatients
AT wuchaoyang distinctivemicrornaexpressioninearlystagenasopharyngealcarcinomapatients